Department of Pediatric Orthopaedics, Beijing Jishuitan Hospital, Peking University, Beijing, China.
Orthop Surg. 2021 Oct;13(7):2102-2110. doi: 10.1111/os.13153. Epub 2021 Oct 2.
To review the outcomes of surgical management in the pediatric patients with extremity chondroblastoma. Especially the risk factors of recurrence and growth disorder. And discuss a potential method to decrease the rate of growth disorder by preventing the premature physeal closure.
Fifteen girls and twenty-seven boys aged from two to 14 years (mean, 11 years) with histologically proven chondroblastoma, who presented from January 2011 to June 2018 at our Hospital, were retrospectively reviewed. Clinical data, radiographic images, histological findings, treatment, functional outcomes, and local recurrence rate were analyzed. Surgical treatment included complete curettage of the tumor and the walls of the lesion followed by bone grafting, No adjuvant methods were used. Recurrence was defined as a return of symptoms and an expansion radiolucency at the operated site. It was confirmed by the histopathological analysis. When recurrence was diagnosed, the medical data were analyzed to detect the effect of different factors on local recurrence. Functional outcome was measured according to Sailhan's functional criteria, designed to provide a standardized method of assessing pediatric chondroblastoma patient postoperatively.
The proximal part of the femur was the most frequently involved site. All the patients had at least 24 months of follow-up; mean duration was 30 months (range, 24-60 months). The local recurrence rate was 9.5%. Three resolved after repeat surgeries without further recurrence, one had a second recurrence and received another more aggressive curettage. Local recurrence of chondroblastoma was associated with age (P < 0.05), while not associated with sex, tumor location, the radiological character of the lesion or the grafting method (P > 0.05). No pulmonary metastasis was noted at latest follow-up. Five patients suffered from premature closure of physis due to physis injury. Thirty-one patients (73.8%) had a good outcome, and all returned to normal unrestricted activities. Six patients (14.3%) had a fair outcome due to occasional pain, asymmetric range of motion, or radiographic joint changes without arthritis. And five patients (11.9%) had a poor outcome because of chronic pain, loss of joint motion impairing normal life activities, or a limb-length discrepancy and limp.
Aggressive curettage and bone grafting resulted in local control and good outcomes in most pediatric patients. Being less than 12 years of age was the risk factor for recurrence. For those growing patients, premature physeal closure was observed after the curettage, interpositional technique with PMMA would be a good choice for prevention.
回顾儿童肢体软骨母细胞瘤的手术治疗结果。特别是探讨预防骺板过早闭合以降低生长障碍发生率的方法。
回顾性分析 2011 年 1 月至 2018 年 6 月我院收治的 15 例女性和 27 例男性患儿(年龄 2 ~ 14 岁,平均 11 岁)的临床资料、影像学表现、组织学特征、治疗方法、功能结果和局部复发率。所有患儿均行肿瘤及病灶壁完整切除术,并行植骨术。术后未采用辅助治疗。局部复发定义为:术区出现症状和扩张性透亮区,经组织病理学分析证实。当诊断为局部复发时,分析其与不同因素的关系。功能结果采用 Sailhan 功能标准进行评估,该标准旨在为术后儿童软骨母细胞瘤患者提供标准化的评估方法。
最常累及股骨近端。所有患儿均获得至少 24 个月的随访,平均随访 30 个月(24 ~ 60 个月)。局部复发率为 9.5%。3 例经再次手术治愈,无进一步复发;1 例复发后行更激进的刮除术。软骨母细胞瘤的局部复发与年龄有关(P < 0.05),与性别、肿瘤位置、病灶的影像学特征或植骨方法无关(P > 0.05)。末次随访时无肺转移。5 例因骺板损伤导致骺板过早闭合。31 例(73.8%)患儿预后良好,均恢复正常活动。6 例(14.3%)患儿因偶有疼痛、关节活动不对称或影像学关节改变但无关节炎而预后一般。5 例(11.9%)患儿因慢性疼痛、关节活动丧失影响正常生活活动或肢体长度差异和跛行而预后较差。
在大多数儿童患者中,彻底刮除和植骨可实现局部控制和良好的预后。年龄<12 岁是复发的危险因素。对于生长中的患儿,刮除术后可观察到骺板过早闭合,PMMA 间隔技术是预防的良好选择。